GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » ROE %

Awakn Life Sciences (XCNQ:AWKN) ROE % : 0.00% (As of Oct. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Awakn Life Sciences's annualized net income for the quarter that ended in Oct. 2024 was C$-1.50 Mil. Awakn Life Sciences's average Total Stockholders Equity over the quarter that ended in Oct. 2024 was C$-1.54 Mil. Therefore, Awakn Life Sciences's annualized ROE % for the quarter that ended in Oct. 2024 was N/A%.

The historical rank and industry rank for Awakn Life Sciences's ROE % or its related term are showing as below:

XCNQ:AWKN's ROE % is not ranked *
in the Biotechnology industry.
Industry Median: -42.19
* Ranked among companies with meaningful ROE % only.

Awakn Life Sciences ROE % Historical Data

The historical data trend for Awakn Life Sciences's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences ROE % Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
ROE %
-337.20 -852.96 -453.25 -

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Awakn Life Sciences's ROE %

For the Biotechnology subindustry, Awakn Life Sciences's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's ROE % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's ROE % falls into.



Awakn Life Sciences ROE % Calculation

Awakn Life Sciences's annualized ROE % for the fiscal year that ended in Jan. 2024 is calculated as

ROE %=Net Income (A: Jan. 2024 )/( (Total Stockholders Equity (A: Jan. 2023 )+Total Stockholders Equity (A: Jan. 2024 ))/ count )
=-5.103/( (0.848+-1.53)/ 2 )
=-5.103/-0.341
=N/A %

Awakn Life Sciences's annualized ROE % for the quarter that ended in Oct. 2024 is calculated as

ROE %=Net Income (Q: Oct. 2024 )/( (Total Stockholders Equity (Q: Jul. 2024 )+Total Stockholders Equity (Q: Oct. 2024 ))/ count )
=-1.504/( (-1.563+-1.523)/ 2 )
=-1.504/-1.543
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Oct. 2024) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Awakn Life Sciences  (XCNQ:AWKN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Oct. 2024 )
=Net Income/Total Stockholders Equity
=-1.504/-1.543
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.504 / 0.016)*(0.016 / 0.7835)*(0.7835 / -1.543)
=Net Margin %*Asset Turnover*Equity Multiplier
=-9400 %*0.0204*N/A
=ROA %*Equity Multiplier
=-191.76 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Oct. 2024 )
=Net Income/Total Stockholders Equity
=-1.504/-1.543
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.504 / -1.504) * (-1.504 / -1.888) * (-1.888 / 0.016) * (0.016 / 0.7835) * (0.7835 / -1.543)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.7966 * -11800 % * 0.0204 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Oct. 2024) net income data. The Revenue data used here is four times the quarterly (Oct. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Awakn Life Sciences ROE % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines